Fentanyl inhibits proliferation and invasion via enhancing miR‑302b expression in esophageal squamous cell carcinoma

Wang,Ning; Zhang,Zhenni; Lv,Jianrui

doi:10.3892/ol.2018.8616

Fentanyl inhibits proliferation and invasion via enhancing miR‑302b expression in esophageal squamous cell carcinoma

Authors:
- Ning Wang
- Zhenni Zhang
- Jianrui Lv
View Affiliations

Affiliations: Department of Anesthesiology, Second Affiliated Hospital, Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710002, P.R. China
Published online on: May 2, 2018 https://doi.org/10.3892/ol.2018.8616
Pages: 459-466

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fentanyl is one of the most commonly used intravenous anesthetic agents during cancer resection surgery, but the effect of fentanyl on esophageal squamous cell carcinoma (ESCC) remains unclear. The aim of the present study was to investigate the involvement of microRNA 302b (miR‑302b) in the anti‑proliferation and anti‑invasion effects of fentanyl in ESCC. In the present study, the effects of fentanyl on cell proliferation, apoptosis and invasion were detected using MTT assays, flow cytometry and Transwell assays in ESCC Eca109 and TE1 cell lines. Subsequently, expression of miR‑302b was determined using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). RT‑qPCR and western blot analysis were performed in order to evaluate the expression of ErbB4, a target of miR‑302b. Furthermore, anti‑miR were used to inhibit miR‑302b in fentanyl‑treated ESCC cells in order to evaluate the role of miR‑302b in the effect of fentanyl on malignant behaviors. Fentanyl inhibited the proliferation of Eca109 and TE1 cells in a dose‑ and time‑dependent manner. Following exposure to fentanyl for 48 h, Eca109 and TE1 cells exhibited increased apoptosis and decreased invasion. Furthermore, fentanyl upregulated miR‑302b expression, but downregulated ErbB4 expression. Finally, loss of miR‑302b using the anti‑miR technique reversed the effect of fentanyl on cell proliferation, apoptosis and invasion in the two ESCC cell lines. Taken together, the results of the present study indicated that fentanyl inhibits the proliferation and invasion of ESCC cells through upregulation of miR‑302b.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
3	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
4	Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P and Chou R: Opioid prescribing: A systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med. 160:38–47. 2014. View Article : Google Scholar : PubMed/NCBI
5	Mercadante S: Fentanyl buccal tablet for the treatment of cancer-related breakthrough pain. Expert Rev Clin Pharmacol. 8:9–13. 2015. View Article : Google Scholar : PubMed/NCBI
6	Qin Y, Li L, Chen J, Tang X, Liao C, Xie Y and Xiao Q: Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitro. Oncol Res. 20:61–69. 2012. View Article : Google Scholar : PubMed/NCBI
7	Nomura Y, Kawaraguchi Y, Sugimoto H, Furuya H and Kawaguchi M: Effects of morphine and fentanyl on 5-fluorouracil sensitivity in human colon cancer HCT116 cells. J Anesth. 28:298–301. 2014. View Article : Google Scholar : PubMed/NCBI
8	Zhang XL, Chen ML and Zhou SL: Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin. Int J Clin Exp Pathol. 8:227–235. 2015.PubMed/NCBI
9	Li AX, Xin WQ and Ma CG: Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR. Biochem Biophys Res Commun. 465:594–600. 2015. View Article : Google Scholar : PubMed/NCBI
10	Miao J, Wang L, Chen L, Yang T, Jin L and Lin L: Fentanyl inhibits cell viability in human pancreatic cancer cell line and tumor growth in pancreatic cancer cell-transplanted mice. Int J Clin Exp Med. 8:17684–17693. 2015.PubMed/NCBI
11	Ohtsuka M, Ling H, Doki Y, Mori M and Calin GA: MicroRNA processing and human cancer. J Clin Med. 4:1651–1667. 2015. View Article : Google Scholar : PubMed/NCBI
12	Zhang M, Zhou S, Zhang L, Zhang J, Cai H, Zhu J, Huang C and Wang J: miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
13	Zhang M, Yang Q, Zhang L, Zhou S, Ye W, Yao Q, Li Z, Huang C, Wen Q and Wang J: miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. J Exp Clin Cancer Res. 33:102014. View Article : Google Scholar : PubMed/NCBI
14	Zhou S, Ye W, Ren J, Shao Q, Qi Y, Liang J and Zhang M: MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma. Am J Cancer Res. 5:267–277. 2014.PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Ciechanowicz SJ and Ma D: Anaesthesia for oncological surgery-can it really influence cancer recurrence? Anaesthesia. 71:127–131. 2016. View Article : Google Scholar : PubMed/NCBI
17	Santamaria LB, Schifilliti D, La Torre D and Fodale V: Drugs of anaesthesia and cancer. Surg Oncol. 19:63–81. 2010. View Article : Google Scholar : PubMed/NCBI
18	Tai YH, Wu HL, Chang WK, Tsou MY, Chen HH and Chang KY: Intraoperative fentanyl consumption does not impact cancer recurrence or overall survival after curative colorectal cancer resection. Sci Rep. 7:108162017. View Article : Google Scholar : PubMed/NCBI
19	Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT and Ying SY: Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 14:2115–2124. 2008. View Article : Google Scholar : PubMed/NCBI
20	Wang L, Yao J, Shi X, Hu L, Li Z, Song T and Huang C: MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer. 13:4482013. View Article : Google Scholar : PubMed/NCBI
21	Wang L, Yao J, Zhang X, Guo B, Le X, Cubberly M, Li Z, Nan K, Song T and Huang C: miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2. Mol Cancer Res. 12:190–202. 2014. View Article : Google Scholar : PubMed/NCBI
22	Zhang Y, Hu H, Song L, Cai L, Wei R and Jin W: Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation. Toxicol Lett. 222:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
23	Chen PH, Shih CM, Chang WC, Cheng CH, Lin CW, Ho KH, Su PC and Chen KC: MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis. J Neurochem. 131:731–742. 2014. View Article : Google Scholar : PubMed/NCBI
24	Cai D, He K, Chang S, Tong D and Huang C: MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma Cell Lines to 5-FU via Targeting Mcl-1 and DPYD. Int J Mol Sci. 16:23668–23682. 2015. View Article : Google Scholar : PubMed/NCBI
25	Cataldo A, Cheung DG, Balsari A, Tagliabue E, Coppola V, Iorio MV, Palmieri D and Croce CM: miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 7:786–797. 2016. View Article : Google Scholar : PubMed/NCBI
26	Zhang L, Ma J, Han Y, Liu J, Zhou W, Hong L and Fan D: Targeted therapy in esophageal cancer. Expert Rev Gastroenterol Hepatol. 10:595–604. 2016. View Article : Google Scholar : PubMed/NCBI
27	Xu S, Kitayama J, Yamashita H, Souma D and Nagawa H: Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma. J Surg Oncol. 97:44–50. 2008. View Article : Google Scholar : PubMed/NCBI
28	Zhao K, Chen BJ and Chen ZG: ErbB4 as a potential molecular target in the treatment of esophageal squamous cell cancers. ScientificWorldJournal. 2014:1241052014. View Article : Google Scholar : PubMed/NCBI